Brian A. Markison

Insider Reports History

Identity Who this page is about. 1 identity field
Location
Bristol, TN
SEC source record Original filing metadata and source links. 1 source field
Owner filing signature
/s/ Eric M. Green, attorney-in-fact
Source evidence Original filing metadata and source links. 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brian A. Markison

Form 4 holding CEO, Director

Lantheus Holdings, Inc.

Security class
Common Stock
Shares / value
232,420
Estimated value
$22,047,361
Report date
05 Mar 2025
Price
$94.86
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

RVL Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
2,976,020
Estimated value
$92,852
Report date
08 Aug 2022
Price
$0.0312
Ownership
Direct
Form 4 holding CEO, Director

Lantheus Holdings, Inc.

Security class
Stock Option (right to buy)
Shares / value
41,347
Estimated value
Report date
05 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Brian A. Markison

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .